Bacterial production of latarcin 2a, a potent antimicrobial peptide from spider venom

Protein Expression and Purification

Volumn 60, Issue 1, 2008, Pages 89-95

  Shlyapnikov, Yuri M ^a   Andreev, Yaroslav A ^a   Kozlov, Sergey A ^a   Vassilevski, Alexander A ^a   Grishin, Eugene V ^a  

^a SHEMYAKIN OVCHINNIKOV INSTITUTE OF BIOORGANIC CHEMISTRY   (Russian Federation)

Author keywords

Antimicrobial peptides; Bacterial expression; Cyanogen bromide cleavage; Cytolytic peptides; Latarcins; Membrane active peptides; Protein precursors; Spider venom

Indexed keywords

ANTIINFECTIVE AGENT; ANTIMICROBIAL CATIONIC PEPTIDE; HYBRID PROTEIN; LARARCIN 2A; SPIDER VENOM; THIOREDOXIN;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; BACILLUS SUBTILIS; BIOSYNTHESIS; CHEMISTRY; DIMERIZATION; DRUG EFFECT; ESCHERICHIA COLI; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; MOLECULAR GENETICS;

AMINO ACID SEQUENCE; ANIMALS; ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; BACILLUS SUBTILIS; DIMERIZATION; ESCHERICHIA COLI; MOLECULAR SEQUENCE DATA; RECOMBINANT FUSION PROTEINS; SPIDER VENOMS; THIOREDOXINS;

ANIMALIA; ARANEAE; BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

EID: 43849098248     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2008.03.011     Document Type: Article

References (40)

1. Menez A., Stocklin R., and Mebs D. 'Venomics' or: the venomous systems genome project. Toxicon 47 (2006) 255-259
2. Escoubas P., and Rash L. Tarantulas: eight-legged pharmacists and combinatorial chemists. Toxicon 43 (2004) 555-574
3. Olivera B.M., McIntosh J.M., Cruz L.J., Luque F.A., and Gray W.R. Purification and sequence of a presynaptic peptide toxin from Conus geographus venom. Biochemistry 23 (1984) 5087-5090
4. Mintz I.M., Venema V.J., Swiderek K.M., Lee T.D., Bean B.P., and Adams M.E. P-type calcium channels blocked by the spider toxin omega-Aga-IVA. Nature 355 (1992) 827-829
5. Kosen P.A., Finer-Moore J., McCarthy M.P., and Basus V.J. Structural studies of alpha-bungarotoxin 3. Corrections in the primary sequence and X-ray structure and characterization of an isotoxic alpha-bungarotoxin. Biochemistry 27 (1988) 2775-2781
6. Miljanich G.P. Ziconotide: neuronal calcium channel blocker for treating severe chronic pain. Curr. Med. Chem. 11 (2004) 3029-3040
7. Kuhn-Nentwig L. Antimicrobial and cytolytic peptides of venomous arthropods. Cell. Mol. Life Sci. 60 (2003) 2651-2668
8. Tossi A., Sandri L., and Giangaspero A. Amphipathic alpha-helical antimicrobial peptides. Biopolymers 55 (2000) 4-30
9. Habermann E., and Jentsch J. Sequence analysis of melittin from tryptic and peptic degradation products. Hoppe-Seyler's Z. Physiol. Chem. 348 (1967) 37-50
10. Kuhn-Nentwig L., Muller J., Schaller J., Walz A., Dathe M., Nentwig W., and 1 C. a new family of highly basic antimicrobial peptides in the venom of the spider Cupiennius salei (Ctenidae). J. Biol. Chem. 277 (2002) 11208-11216
11. Corzo G., Villegas E., Gomez-Lagunas F., Possani L.D., Belokoneva O.S., and Nakajima T. Oxyopinins large amphipathic peptides isolated from the venom of the wolf spider Oxyopes kitabensis with cytolytic properties and positive insecticidal cooperativity with spider neurotoxins. J. Biol. Chem. 277 (2002) 23627-23637
12. Kozlov S.A., Vassilevski A.A., Feofanov A.V., Surovoy A.Y., Karpunin D.V., and Grishin E.V. Latarcins antimicrobial and cytolytic peptides from the venom of the spider Lachesana tarabaevi (Zodariidae) that exemplify biomolecular diversity. J. Biol. Chem. 281 (2006) 20983-20992
13. A.A. Vassilevski, S.A. Kozlov, O.V. Samsonova, N.S. Egorova, D.V. Karpunin, K.A. Pluzhnikov, A.V. Feofanov, E.V. Grishin, Cyto-insectotoxins, a novel class of cytolytic and insecticidal peptides, Biochem. J. (2008) doi:10.1042/bj20071123.
14. Vassilevski A.A., Kozlov S.A., and Grishin E.V. Antimicrobial peptide precursor structures suggest effective production strategies. Recent Patents Inflamm. Allergy Drug Discov. 2 (2008) 58-63
15. Piers K.L., Brown M.H., and Hancock R.E.W. Recombinant DNA procedures for producing small antimicrobial cationic peptides in bacteria. Gene 134 (1993) 7-13
16. Zhang L., Falla T., Wu M., Fidai S., Burian J., Kay W., and Hancock R.E. Determinants of recombinant production of antimicrobial cationic peptides and creation of peptide variants in bacteria. Biochem. Biophys. Res. Commun. 247 (1998) 674-680
17. 13 C. J. Biomol. NMR 12 (1998) 109-121
18. Wang Y.Q., and Cai J.Y. High-level expression of acidic partner-mediated antimicrobial peptide from tandem genes in Escherichia coli. Appl. Biochem. Biotechnol. 141 (2007) 203-213
19. Shi W.J., Xu H.J., Cheng J.A., and Zhang C.X. Expression of the melittin gene of Apis cerana cerana in Escherichia coli. Protein Expr. Purif. 37 (2004) 213-219
20. Dubovskii P.V., Volynsky P.E., Polyansky A.A., Chupin V.V., Efremov R.G., and Arseniev A.S. Spatial structure and activity mechanism of a novel spider antimicrobial peptide. Biochemistry 45 (2006) 10759-10767
21. Polyansky A.A., Volynsky P.E., and Efremov R.G. Computer simulations of membrane-lytic peptides: perspectives in drug design. J. Bioinform. Comput. Biol. 5 (2007) 611-626
22. Forstner M., Leder L., and Mayr L.M. Optimization of protein expression systems for modern drug discovery. Expert Rev. Proteomics 4 (2007) 67-78
23. Schmidt F.R. Recombinant expression systems in the pharmaceutical industry. Appl. Microbiol. Biotechnol. 65 (2004) 363-372
24. Skosyrev V.S., Rudenko N.V., Yakhnin A.V., Zagranichny V.E., Popova L.I., Zakharov M.V., Gorokhovatsky A.Y., and Vinokurov L.M. EGFP as a fusion partner for the expression and organic extraction of small polypeptides. Protein Expr. Purif. 27 (2003) 55-62
25. Xu X., Jin F., Yu X., Ren S., Hu J., and Zhang W. High-level expression of the recombinant hybrid peptide cecropin A(1-8)-magainin2(1-12) with an ubiquitin fusion partner in Escherichia coli. Protein Expr. Purif. 55 (2007) 175-182
26. Hwang S.W., Lee J.H., Park H.B., Pyo S.H., So J.E., Lee H.S., Hong S.S., and Kim J.H. A simple method for the purification of an antimicrobial peptide in recombinant Escherichia coli. Mol. Biotechnol. 18 (2001) 193-198
27. Li Y., Li X., and Wang G. Cloning, expression, isotope labeling, and purification of human antimicrobial peptide LL-37 in Escherichia coli for NMR studies. Protein Expr. Purif. 47 (2006) 498-505
28. Xu X., Jin F., Yu X., Ji S., Wang J., Cheng H., Wang C., and Zhang W. Expression and purification of a recombinant antibacterial peptide, cecropin, from Escherichia coli. Protein Expr. Purif. 53 (2007) 293-301
29. Xu Z., Peng L., Zhong Z., Fang X., and Cen P. High-level expression of a soluble functional antimicrobial peptide, human beta-defensin 2, in Escherichia coli. Biotechnol. Prog. 22 (2006) 382-386
30. + channels. Toxicon 50 (2007) 993-1004
31. Lee J.H., Minn I., Park C.B., and Kim S.C. Acidic peptide-mediated expression of the antimicrobial peptide buforin II as tandem repeats in Escherichia coli. Protein Expr. Purif. 12 (1998) 53-60
32. Kim H.K., Chun D.S., Kim J.S., Yun C.H., Lee J.H., Hong S.K., and Kang D.K. Expression of the cationic antimicrobial peptide lactoferricin fused with the anionic peptide in Escherichia coli. Appl. Microbiol. Biotechnol. 72 (2006) 330-338
33. Morin K.M., Arcidiacono S., Beckwitt R., and Mello C.M. Recombinant expression of indolicidin concatamers in Escherichia coli. Appl. Microbiol. Biotechnol. 70 (2006) 698-704
34. Tian Z.G., Teng D., Yang Y.L., Luo J., Feng X.J., Fan Y., Zhang F., and Wang J.H. Multimerization and fusion expression of bovine lactoferricin derivative LfcinB15-W4,10 in Escherichia coli. Appl. Microbiol. Biotechnol. 75 (2007) 117-124
35. Cipakova I., Gasperik J., and Hostinova E. Expression and purification of human antimicrobial peptide, dermcidin, in Escherichia coli. Protein Expr. Purif. 45 (2006) 269-274
36. Pazgier M., and Lubkowski J. Expression and purification of recombinant human alpha-defensins in Escherichia coli. Protein Expr. Purif. 49 (2006) 1-8
37. Lee J.H., Kim J.H., Hwang S.W., Lee W.J., Yoon H.K., Lee H.S., and Hong S.S. High-level expression of antimicrobial peptide mediated by a fusion partner reinforcing formation of inclusion bodies. Biochem. Biophys. Res. Commun. 277 (2000) 575-580
38. Wei Q., Kim Y.S., Seo J.H., Jang W.S., Lee I.H., and Cha H.J. Facilitation of expression and purification of an antimicrobial peptide by fusion with baculoviral polyhedrin in Escherichia coli. Appl. Environ. Microbiol. 71 (2005) 5038-5043
39. Rao X.C., Li S., Hu J.C., Jin X.L., Hu X.M., Huang J.J., Chen Z.J., Zhu J.M., and Hu F.Q. A novel carrier molecule for high-level expression of peptide antibiotics in Escherichia coli. Protein Expr. Purif. 36 (2004) 11-18
40. Brogden K.A. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?. Nat. Rev. Microbiol. 3 (2005) 238-250